https://powerbase.info/index.php?title=Ghostwriting&feed=atom&action=historyGhostwriting - Revision history2024-03-28T17:19:58ZRevision history for this page on the wikiMediaWiki 1.31.5https://powerbase.info/index.php?title=Ghostwriting&diff=106936&oldid=prevMarisa de Andrade at 20:07, 10 February 20102010-02-10T20:07:47Z<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 20:07, 10 February 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Template:Pharma_Portal_badge}}  </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Template:Pharma_Portal_badge}}  </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">''''Ghostwriting'''' in medical literature occurs when 'someone makes substantial contributions to a manuscript without attribution or disclosure'. Critics consider this to be an act of 'scientific misconduct' and it is generally considered 'bad publication practice'.<ref>Gøtzsche PC, Kassirer JP, Woolley KL, Wager E, Jacobs A, et al. (2009) What Should Be Done To Tackle Ghostwriting in the Medical Literature? PLoS Med 6(2): e1000023. doi:10.1371/journal.pmed.1000023</ref></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Actonel==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Actonel==</div></td></tr>
</table>Marisa de Andradehttps://powerbase.info/index.php?title=Ghostwriting&diff=105326&oldid=prevMarisa de Andrade: /* Actonel */2010-01-23T23:48:02Z<p><span dir="auto"><span class="autocomment">Actonel</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 23:48, 23 January 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Line 5:</td>
<td colspan="2" class="diff-lineno">Line 5:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist faced disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] summoned Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref> In November 2009, the GMC's Fitness to Practise (FTP) Panel concluded Eastell's conduct was not dishonest:  </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist faced disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] summoned Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref> In November 2009, the GMC's Fitness to Practise (FTP) Panel concluded Eastell's conduct was not dishonest:  </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:'Your failure to correct the statement before its publication in the JBMR [Journal of Bone and Mineral Research] occurred in 2002, when there was an evolving understanding of access to data. You did not knowingly allow inaccurate information to be published.' <ref> GMC Fitness to Practise Panel minutes. 2-5 November 2009 [http://www.gmc-uk.org/static/documents/content/Anon_Eastell_Minutes.pdf Eastell Minutes] Accessed 23 January 2010.</ref></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:'Your failure to correct the statement before its publication in the JBMR [Journal of Bone and Mineral Research] occurred in 2002, when there was an evolving understanding of access to data. You did not knowingly allow inaccurate information to be published.' <ref> GMC Fitness to Practise Panel minutes. 2-5 November 2009 [</div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>http://www.gmc-uk.org/static/documents/content/Anon_Eastell_Minutes.pdf Eastell Minutes] Accessed 23 January 2010.</ref></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Aubrey Blumsohn who made the initial complaint to the GMC said:</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>Aubrey Blumsohn who made the initial complaint to the GMC said:</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>:'The GMC has done an important job in helping to define the meaning of data and the responsibilities of scientific authors… The council has determined that access to data to authors means proper unfettered access to raw data so that authors can check findings reported in their names. Scientists would otherwise be indistinguishable from clowns.'<ref>Baty, P. 10 November 2009. ''Times Higher Education.'' [http://www.timeshighereducation.co.uk/story.asp?storycode=409013 Academic made ‘untrue’ declaration about ‘full access’ to research material, GMC finds] Accessed 23 January 2010.</ref></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>:'The GMC has done an important job in helping to define the meaning of data and the responsibilities of scientific authors… The council has determined that access to data to authors means proper unfettered access to raw data so that authors can check findings reported in their names. Scientists would otherwise be indistinguishable from clowns.'<ref>Baty, P. 10 November 2009. ''Times Higher Education.'' [</div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>http://www.timeshighereducation.co.uk/story.asp?storycode=409013 Academic made ‘untrue’ declaration about ‘full access’ to research material, GMC finds] Accessed 23 January 2010.</ref></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Caspper==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Caspper==</div></td></tr>
</table>Marisa de Andradehttps://powerbase.info/index.php?title=Ghostwriting&diff=105325&oldid=prevMarisa de Andrade: /* Actonel */2010-01-23T23:46:15Z<p><span dir="auto"><span class="autocomment">Actonel</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 23:46, 23 January 2010</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3" >Line 3:</td>
<td colspan="2" class="diff-lineno">Line 3:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Actonel==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Actonel==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist <del class="diffchange diffchange-inline">is facing </del>disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] <del class="diffchange diffchange-inline">will summon </del>Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist <ins class="diffchange diffchange-inline">faced </ins>disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] <ins class="diffchange diffchange-inline">summoned </ins>Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009<ins class="diffchange diffchange-inline">.</ref> In November 2009, the GMC's Fitness to Practise (FTP) Panel concluded Eastell's conduct was not dishonest: </ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">:'Your failure to correct the statement before its publication in the JBMR [Journal of Bone and Mineral Research] occurred in 2002, when there was an evolving understanding of access to data. You did not knowingly allow inaccurate information to be published.' <ref> GMC Fitness to Practise Panel minutes. 2-5 November 2009 [</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">http://www.gmc-uk.org/static/documents/content/Anon_Eastell_Minutes.pdf Eastell Minutes] Accessed 23 January 2010.</ref></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Aubrey Blumsohn who made the initial complaint to the GMC said:</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">:'The GMC has done an important job in helping to define the meaning of data and the responsibilities of scientific authors… The council has determined that access to data to authors means proper unfettered access to raw data so that authors can check findings reported in their names. Scientists would otherwise be indistinguishable from clowns.'<ref>Baty, P. 10 November 2009. ''Times Higher Education.'' [</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">http://www.timeshighereducation.co.uk/story.asp?storycode=409013 Academic made ‘untrue’ declaration about ‘full access’ to research material, GMC finds] Accessed 23 January 2010</ins>.</ref></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Caspper==</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Caspper==</div></td></tr>
</table>Marisa de Andradehttps://powerbase.info/index.php?title=Ghostwriting&diff=96730&oldid=prevClaire Robinson at 09:19, 21 September 20092009-09-21T09:19:21Z<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 09:19, 21 September 2009</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Template:Pharma_Portal_badge}}  </div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Template:Pharma_Portal_badge}}  </div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>==<del class="diffchange diffchange-inline">Ghost Writing</del>==</div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>==<ins class="diffchange diffchange-inline">Actonel</ins>==</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div> </div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">'''Actonel'''</del></div></td><td colspan="2"> </td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist is facing disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] will summon Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone specialist is facing disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] will summon Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del class="diffchange diffchange-inline">'''</del>Caspper<del class="diffchange diffchange-inline">'''</del></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">==</ins>Caspper<ins class="diffchange diffchange-inline">==</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that [[GlaxoSmithKline]] hired a ghostwriting programme named [[Caspper]] in which doctors could take credit for medical journal articles written by the company's consultants. According to documents held by a US law firm, the project was aimed at increasing America sales of the antidepressant paroxetine otherwise known as [[Paxil]] in the US and [[Seroxat]] in the UK. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that [[GlaxoSmithKline]] hired a ghostwriting programme named [[Caspper]] in which doctors could take credit for medical journal articles written by the company's consultants. According to documents held by a US law firm, the project was aimed at increasing America sales of the antidepressant paroxetine otherwise known as [[Paxil]] in the US and [[Seroxat]] in the UK. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td></tr>
</table>Claire Robinsonhttps://powerbase.info/index.php?title=Ghostwriting&diff=96729&oldid=prevClaire Robinson at 09:13, 21 September 20092009-09-21T09:13:04Z<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 09:13, 21 September 2009</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Line 5:</td>
<td colspan="2" class="diff-lineno">Line 5:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Actonel'''</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Actonel'''</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone <del class="diffchange diffchange-inline">specialists </del>is facing disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] will summon Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>In September 2009, the Guardian reported that a leading British bone <ins class="diffchange diffchange-inline">specialist </ins>is facing disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] will summon Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research  British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Caspper'''</div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>'''Caspper'''</div></td></tr>
</table>Claire Robinsonhttps://powerbase.info/index.php?title=Ghostwriting&diff=96727&oldid=prevMarisa de Andrade: New page: {{Template:Pharma_Portal_badge}} ==Ghost Writing== '''Actonel''' In September 2009, the Guardian reported that a leading British bone specialists is facing disciplinary action over acc...2009-09-20T21:58:51Z<p>New page: {{Template:Pharma_Portal_badge}} ==Ghost Writing== '''Actonel''' In September 2009, the Guardian reported that a leading British bone specialists is facing disciplinary action over acc...</p>
<p><b>New page</b></p><div>{{Template:Pharma_Portal_badge}} <br />
<br />
==Ghost Writing==<br />
<br />
'''Actonel'''<br />
<br />
In September 2009, the Guardian reported that a leading British bone specialists is facing disciplinary action over accusations that he was involved in "ghost writing". The [[General Medical Council]] will summon Professor [[Richard Eastell]] from Sheffield University to a committee meeting. He admitted to agreeing to have his name used as first author of a study on the osteoporosis drug [[Actonel]] even though he did not have access to all the data on which the study's conclusions were based. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref><br />
<br />
'''Caspper'''<br />
<br />
In September 2009, the Guardian reported that [[GlaxoSmithKline]] hired a ghostwriting programme named [[Caspper]] in which doctors could take credit for medical journal articles written by the company's consultants. According to documents held by a US law firm, the project was aimed at increasing America sales of the antidepressant paroxetine otherwise known as [[Paxil]] in the US and [[Seroxat]] in the UK. <ref>Bosely, S. [http://www.guardian.co.uk/science/2009/sep/18/doctors-ghost-writing-pharmaceutical-research British doctor faces action over claims of 'ghost writing' for US drug company]. The Guardian. Accessed on 20 September 2009.</ref><br />
<br />
==Notes==<br />
<references/></div>Marisa de Andrade